Skip to content

Vaccine Expansion Exploration

Dear AFHTO Physician Leads and EDs,
 
The Ministry of Health is assessing the potential for expanded routine vaccine administration in the pharmacy channel.

The Ministry is assessing the potential expansion of routine vaccines via the pharmacy channel, considering access (e.g., connected care) and logistics as part of this work. This is being undertaken as the province looks to connect every person in Ontario to the care they need when they need it. The right care in the right place, faster access to care and maximizing the skills and full potential of health care professionals.
 
For the Ministry assessment, vaccines are being looked at as four bundles based on life stages, childhood, school-based, adolescent / adult Tdap and older adult/older adult (See Appendix A). Ontario high-risk vaccine programs are not being considered as part of this assessment.  
 
The Ministry is seeking stakeholder input and perspectives on the potential expansion of publicly funded vaccine in the pharmacy channel per the bundles of routine vaccines. This assessment is being undertaken as information gathering only at this time, there is no commitment on moving forward with the outcomes of the assessment.
We ask that you please take the time to complete the questions below no later than August 14.  
Your name
Email address
Organization
Please select your profession
1. Do you have any concerns about pharmacy-based vaccinations? (i.e., admin burden, communications, system costs, etc.).
What are your concerns, if any:
2. Do you recommend Routine Vaccine Bundle 1: Childhood vaccines (Diphtheria, Tetanus, Pertussis, Polio, Haemophilus influenzae, Pneumococcal, Rotavirus, MMR, Meningococcal, Varicella) be expanded into the pharmacy channel
With regards to your organization, what are the implications of this (potential) expansion to pharmacies?
3. Do you recommend Routine Vaccine Bundle 2: School-based Vaccines: -Hepatitis B ​-Men C-ACYW135​, HPV be expanded into the pharmacy channel?
With regards to your organization, what are the implications of this (potential) expansion to pharmacies?
4. Do you recommend Routine Vaccine Bundle 3: Adolescent Tetanus diphtheria & pertussis (Tdap), Adult Tdap (Including pregnancy)be expanded into the pharmacy channel?
With regards to your organization, what are the implications of this (potential) expansion to pharmacies?
5. Do you recommend Routine Vaccine Bundle 4: Adult vaccines Tetanus & diphtheria (Td) booster, Pneumococcal (Pneu-P-23), Shingles be expanded into the pharmacy channel?
With regards to your organization, what are the implications of this (potential) expansion to pharmacies?
6. From the perspective of your organization, what are the implications of expanding routine vaccine administration to pharmacies for any or all of the vaccine bundles? Please provide bundle specific details, where applicable (e.g., records management).
7. Are there any other important considerations the Ministry should explore in assessing potential expansion of publicly funded vaccine administration through the pharmacy channel?